Form 4: Itron Director Lande's Stock Grant for Board Service

Itron, Inc. Director Jerome J. Lande received a grant of 529 shares of common stock on January 2, 2026, as part of his annual compensation for board service, increasing his total beneficial ownership to 9,538 shares.

Summary

• Jerome J. Lande, a Director of Itron, Inc. (ITRI), acquired 529 shares of common stock.
• The transaction occurred on January 2, 2026.
• The shares were granted at a price of $0.
• This grant reflects common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
• Following this transaction, Mr. Lande beneficially owns 9,538 shares of Itron common stock directly.

Sentiment

Score: 6

Explanation: The filing reports a routine stock grant to a director as part of their compensation, which is a neutral to slightly positive event as it aligns interests but does not indicate new strategic developments or significant financial performance changes.

Positives

• The grant of common stock to Director Jerome J. Lande aligns his interests with those of shareholders.
• It represents a routine component of compensation for independent board members, indicating stable corporate governance practices.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports a routine insider transaction related to director compensation, which is a standard practice across publicly traded companies to align management and board interests with shareholders. It does not provide specific insights into broader industry trends or competitive positioning.

Corporate Governance

Related Party Transactions

• Director Jerome J. Lande, a related party, received 529 shares of common stock as compensation for his board service.

Stakeholder Impact

• Shareholders: The stock grant to a director helps align the director's financial interests with those of the shareholders, potentially fostering better long-term decision-making.

Key Dates

Recommendation

This Form 4 filing details a routine stock grant to an independent director as part of their compensation. Such transactions are standard practice and do not typically provide new material information that would warrant a change in investment recommendation. The filing confirms ongoing corporate governance practices but offers no insights into the company's operational performance or future prospects to justify a 'buy' or 'sell' decision based solely on this report.

Keywords

Itron, ITRI, Form 4, Insider Transaction, Stock Grant, Director Compensation, Beneficial Ownership, Corporate Governance